Jean-Christophe Beltra

Jean-Christophe Beltra

Auto-generated profile, based on publicly available information

Jean-Christophe Beltra

University of Basel 4 Department of Biomedicine Basel, Switzerland

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 January 2021 in Science Immunology
Verified
Journal Article
Closed access
JJJonathan B. Johnnidis
Jonathan B. Johnnidis
YMYuki Muroyama
Yuki Muroyama
SNShin Foong Ngiow
Shin Foong Ngiow
ZCZeyu Chen
Zeyu Chen
SMSasikanth Manne
Sasikanth Manne
EWE. John Wherry
E. John Wherry
An early memory CD8 + T cell precursor with distinct genome maintenance capacity depends on inhibitory receptor signaling.

16 August 2021 in Journal of Clinical Investigation
Verified
Journal Article
Closed access
PDF file
ETEvgenii N. Tcyganov
Evgenii N. Tcyganov
SHShino Hanabuchi
Shino Hanabuchi
AHAyumi Hashimoto
Ayumi Hashimoto
DCDavid Campbell
David Campbell
GKGozde Kar
Gozde Kar
DGDmitry Gabrilovich
Dmitry Gabrilovich
Myeloid-derived suppressor cells (MDSCs) are major negative regulators of immune responses in cancer and chronic infections. It remains unclear if regulation of MDSC activity in different conditions is controlled by similar mechanisms. We compared MDSCs in mice with cancer and lymphocytic choriomeningitis virus (LCMV) infection. Chronic LCMV infection caused the development of monocytic MDSCs (M-MDSCs) but did not induce polymorphonuclear MDSCs (PMN-MDSCs). In contrast, both MDSC populations were present in cancer models. An acquisition of immune-suppressive activity by PMN-MDSCs in cancer was controlled by IRE1α and ATF6 pathways of the endoplasmic reticulum (ER) stress response. Abrogation of PMN-MDSC activity by blockade of the ER stress response resulted in an increase in tumor-specific immune response and reduced tumor progression. In contrast, the ER stress response was dispensable for suppressive activity of M-MDSCs in cancer and LCMV infection. Acquisition of immune-suppressive activity by M-MDSCs in spleens was mediated by IFN-γ signaling. However, it was dispensable for suppressive activity of M-MDSCs in tumor tissues. Suppressive activity of M-MDSCs in tumors was retained due to the effect of IL-6 present at high concentrations in the tumor site. These results demonstrate disease- and population-specific mechanisms of MDSC accumulation and the need for targeting different pathways to achieve inactivation of these cells.

9 December 2021 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
ELEmma L. Lewis
Emma L. Lewis
RXRong Xu
Rong Xu
JBJean-Christophe Beltra
Jean-Christophe Beltra
SNShin Foong Ngiow
Shin Foong Ngiow
JCJordana Cohen
Jordana Cohen
PPPaige M. Porrett
Paige M. Porrett
Pregnancy is a common immunization event, but the molecular mechanisms and immunological consequences provoked by pregnancy remain largely unknown. We used mouse models and human transplant registry data to reveal that pregnancy induced exhausted CD8 T cells (Preg-TEX), which associated with prolonged allograft survival. Maternal CD8 T cells shared features of exhaustion with CD8 T cells from cancer and chronic infection, including transcriptional down-regulation of ribosomal proteins and up-regulation of TOX and inhibitory receptors. Similar to other models of T cell exhaustion, NFAT-dependent elements of the exhaustion program were induced by fetal antigen in pregnancy, whereas NFAT-independent elements did not require fetal antigen. Despite using conserved molecular circuitry, Preg-TEX cells differed from TEX cells in chronic viral infection with respect to magnitude and dependency of T cell hypofunction on NFAT-independent signals. Altogether, these data reveal the molecular mechanisms and clinical consequences of maternal CD8 T cell hypofunction and identify pregnancy as a previously unappreciated context in which T cell exhaustion may occur.

22 July 2026 in Cancer Immunology Research
Verified
Journal Article
Open access
MSMitra Shourian
Mitra Shourian
BBBenoîte Bourdin
Benoîte Bourdin
NENehme El-Hachem
Nehme El-Hachem
CRClémence Ruisseaux
Clémence Ruisseaux
AVAlexis Vallée
Alexis Vallée
HDHélène Decaluwe
Hélène Decaluwe
T-cell exhaustion remains a barrier to adoptive cell therapies. Although γc cytokines are used to expand T cells, their impact on T-cell states remains incompletely defined. Using an in vitro model of repetitive T-cell receptor stimulation, we found that high-dose interleukin 2 (IL2) or IL15 promoted exhausted CD8+ T-cell (TEX) differentiation, with increased inhibitory receptor expression and loss of stem-like features. During chronic lymphocytic choriomeningitis virus clone 13 infection, high IL2Rβ expression marked virus-specific CD8+ T cells with features of terminally exhausted T cells, whereas IL2Rβ deficiency favored progenitor-like populations. In TEX, IL2 and IL15 preferentially induced STAT5 phosphorylation over other signaling pathways. Genetic disruption of STAT5 similarly supported progenitor subsets, implicating STAT5 in the progression toward more differentiated TEX states under chronic stimulation. We therefore asked whether transient STAT5 attenuation during in vitro T-cell expansion could bias differentiation toward progenitor-like populations without compromising functional competence. Transient JAK3 or STAT5 inhibition enriched TCF1+Ly108+ progenitor–like cells while preserving cytokine production and degranulation capacity. Following transfer into tumor-bearing mice, cells expanded under STAT5-inhibited conditions mediated superior tumor control and prolonged survival. Likewise, transient STAT5 inhibition preserved memory–progenitor phenotypes in human CD22 chimeric antigen receptor T cells without impairing cytotoxicity. RNA sequencing of STAT5 inhibitor–expanded CD8+ T cells confirmed reinforced stem-like transcriptional programs and reduced enrichment of effector and exhausted signatures. Together, these findings identify the IL2Rβ–STAT5 axis as a regulator of CD8+ T-cell differentiation and support transient STAT5 modulation during ex vivo expansion to improve therapeutic T-cell products.